Literature DB >> 6721807

Evaluation of attenuated strains of Mycoplasma gallisepticum as vaccines in young chickens.

M Y Lin, S H Kleven.   

Abstract

Five trials were conducted to evaluate the virulence and the vaccination efficacy of the F, R, S6, and A5969 strains of Mycoplasma gallisepticum (MG) at different in vitro passage levels. Vaccination was done by eye-drop or aerosol, and efficacy was evaluated in terms of air-sac lesions after aerosol challenge with the R strain of MG. Continuing medium passage of these strains of MG resulted in gradual attenuation. Aerosol vaccination with highly attenuated MG at 21 days of age was more effective in stimulating the development of immunity than was eye-drop vaccination at 7 days, but aerosol vaccination induced more air-sac lesions. Aerosol vaccination with high-passaged F or S6 strain provided good immunity against MG challenge. Back-passage in chickens of the F strain of over 300 medium passages did not substantially increase the virulence, but back-passage of the S6 strain at the 258th passage and F strain at the 11th and 252nd passage did result in increased virulence. Both low- and high-passaged F and S6 strains were virulent for turkey poults, but only the high-passage F strain did not significantly (P less than 0.05) affect body weight.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6721807

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  8 in total

1.  Phenotypic switching in Mycoplasma gallisepticum hemadsorption is governed by a high-frequency, reversible point mutation.

Authors:  Florian Winner; Ivana Markovà; Peter Much; Albin Lugmair; Karin Siebert-Gulle; Gunther Vogl; Renate Rosengarten; Christine Citti
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

2.  In vitro cell invasion of Mycoplasma gallisepticum.

Authors:  F Winner; R Rosengarten; C Citti
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

3.  Mycoplasma gallisepticum invades chicken erythrocytes during infection.

Authors:  Gunther Vogl; Astrid Plaickner; Susan Szathmary; László Stipkovits; Renate Rosengarten; Michael P Szostak
Journal:  Infect Immun       Date:  2007-10-22       Impact factor: 3.441

4.  Role of the GapA and CrmA cytadhesins of Mycoplasma gallisepticum in promoting virulence and host colonization.

Authors:  Ivana Indiková; Peter Much; László Stipkovits; Karin Siebert-Gulle; Michael P Szostak; Renate Rosengarten; Christine Citti
Journal:  Infect Immun       Date:  2013-03-04       Impact factor: 3.441

5.  Factors influencing the cell adhesion and invasion capacity of Mycoplasma gallisepticum.

Authors:  Ursula Fürnkranz; Karin Siebert-Gulle; Renate Rosengarten; Michael P Szostak
Journal:  Acta Vet Scand       Date:  2013-09-05       Impact factor: 1.695

6.  First identification of proteins involved in motility of Mycoplasma gallisepticum.

Authors:  Ivana Indikova; Martin Vronka; Michael P Szostak
Journal:  Vet Res       Date:  2014-10-17       Impact factor: 3.683

7.  Identification of Strain-Specific Sequences That Distinguish a Mycoplasma gallisepticum Vaccine Strain from Field Isolates.

Authors:  Camir Ricketts; Larissa Pickler; John Maurer; Saravanaraj Ayyampalayam; Maricarmen García; Naola M Ferguson-Noel
Journal:  J Clin Microbiol       Date:  2016-12-28       Impact factor: 5.948

8.  The expression of GapA and CrmA correlates with the Mycoplasma gallisepticum in vitro infection process in chicken TOCs.

Authors:  Nancy Rüger; Michael P Szostak; Silke Rautenschlein
Journal:  Vet Res       Date:  2022-09-02       Impact factor: 3.829

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.